[1] De Cock KM, Jaffe HW, Curran JW.Reflections on 40 Years of AIDS[J]. Emerg Infect Dis, 2021, 27(6):1553-1560. [2] Cao W, Hsieh E, Li T.Optimizing treatment for adults with HIV/AIDS in China: Successes over two decades and remaining challenges[J]. Curr HIV/AIDS Rep, 2020, 17(1):26-34. [3] 何耀祖, 陈晓婷, 陈景良, 等. 我国艾滋病抗病毒治疗药物变迁及进展[J]. 广东医学, 2023, 44(2):157-160. [4] Kanters S, Socias ME, Paton NI, et al.Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: A systematic review and network meta-analysis[J]. Lancet HIV, 2017, 4(10):e433-e441. [5] Barnes E, Zhao J, Giumenta A, et al.The effect of an integrated health system specialty pharmacy on HIV antiretroviral therapy adherence, viral suppression, and CD4 count in an outpatient infectious disease clinic[J]. J Manag Care Spec Pharm, 2020, 26(2):95-102. [6] 朱洪斌, 于君, 张庚赞, 等. HIV/AIDS青少年抗逆转录病毒治疗依从性研究进展[J]. 护理研究, 2021, 35(21):3868-3872. [7] Abdulrahman SA, Ganasegeran K, Rampal L, et al.HIV treatment adherence-a shared burden for patients, health-care providers, and other stakeholders[J]. AIDS Rev, 2019, 21(1):28-39. [8] Chendi BH, Okomo Assoumou MC, Jacobs GB, et al.Rate of viral load change and adherence of HIV adult patients treated with Efavirenz or Nevirapine antiretroviral regimens at 24 and 48 weeks in Yaoundé, Cameroon: A longitudinal cohort study[J]. BMC Infect Dis, 2019, 19(1):194. [9] Gulick RM, Flexner C.Long-acting HIV drugs for treatment and prevention[J]. Annu Rev Med, 2019, 70:137-150. [10] Zhou J, Yun J, Ye X, et al.Interventions to improve antiretroviral adherence in HIV-infected pregnant women: A systematic review and meta-analysis[J]. Front Public Health, 2022, 10:1056915. [11] 付晓丽, 牛卫理, 杨淑敏, 等. Morisky问卷测量AIDS患者服药依从性的信度和效度[J]. 郑州大学学报(医学版), 2016, 51(3):421-423. [12] Mann SC, Castillo-Mancilla JR. HIV, aging, and adherence:An update and future directions[J]. Curr Opin HIV AIDS, 2020, 15(2):134-141. [13] Wang YY, Jin Y, Chen C, et al.Meta-analysis of adherence to highly active antiretroviral therapy in patients with HIV infection in China[J]. AIDS Care, 2019, 31(8):913-922. [14] Ceylan E, Koç A, İnkaya AÇ, et al.Determination of medication adherence and related factors among people living with HIV/AIDS in a Turkish university hospital[J]. Turk J Med Sci, 2019, 49(1):198-205. [15] 李怡,张潇文,李丽,等.昆明市HIV感染者未接受抗病毒治疗原因及对策分析[J].中国热带医学,2021,21(2):143-147. [16] Chakraborty A, Hershow RC, Qato DM, et al.Adherence to antiretroviral therapy among HIV patients in India: A systematic review and Meta-analysis[J]. AIDS Behav, 2020, 24(7):2130-2148. [17] Qiao YC, Xu Y, Jiang DX, et al.Epidemiological analyses of regional and age differences of HIV/AIDS prevalence in China, 2004-2016[J]. Int J Infect Dis, 2019, 81:215-220. [18] He Q, Hao C, Pan D, et al.Adherence to antiretroviral therapy and its predictive factors among people living with HIV in China: A behavioral theory-based prospective cohort study[J]. Int J Behav Med, 2022. doi:10.1007/s12529-022-10120-7. [19] 阮尉月清, 刘家法, 周熙姝, 等. 老年HIV感染者的流行特征及治疗中存在的问题[J]. 国际流行病学传染病学杂志, 2021, 48(3):241-246. [20] 康文, 孙永涛. 中国HIV感染快速启动抗病毒治疗的获益挑战和模式探索[J]. 中国艾滋病性病, 2020, 26(9):1025-1029. [21] 陈伟烈,何瑞英,雷华丽,等.HAART过程HIV/AIDS患者PBMC中HIV-1前病毒DNA的动态变化及其意义[J].分子诊断与治疗杂志,2018,10(6):390-394,416. [22] 李洪柳, 张建波, 申元英. 静脉与非静脉吸毒感染HIV/AIDS患者的现况对比分析[J]. 大理大学学报, 2019, 4(4):87-89. [23] Altice F, Evuarherhe O, Shina S, et al.Adherence to HIV treatment regimens:Systematic literature review and meta-analysis[J]. Patient Prefer Adherence, 2019, 13:475-490. [24] 罗柳红,黄荣叶,周业胜,等.广西钦州市2008—2018年初始抗病毒治疗HIV感染者死亡和脱失分析[J].中国热带医学,2021,21(12):1123-1129. [25] 楼金成, 杨根, 王林, 等. 云南省艾滋病抗病毒治疗脱失再入组患者疗效及结局分析[J]. 中国艾滋病性病, 2021, 27(5):472-475. |